Michael Li, MD, MPH
Assistant Professor
Medicine
School of Medicine
Dr. Michael Li is a transplant hepatologist and gastroenterologist who specializes in caring for patients with cirrhosis, autoimmune liver disease, and liver cancer.
Show full bio (130 words) Hide full bio
Dr. Li’s research focuses on the relationship between the immune system and liver disease. This includes autoimmune diseases like primary sclerosing cholangitis as well as the use of immunotherapy to treat liver cancer. He seeks to perform meaningful clinical and translational research to achieve a better understanding of immune-mediated liver diseases.
Dr. Li earned his medical degree at the Icahn School of Medicine at Mount Sinai and completed a residency in internal medicine at the Mount Sinai Hospital. He completed a fellowship in gastroenterology at Brigham and Women's Hospital, during which he also earned his MPH degree from the Harvard TH Chan School of Public Health. He then completed a fellowship in transplant hepatology at UCSF before becoming a faculty member in the UCSF Division of Gastroenterology and Hepatology.
Awards
Show all (11) Hide
- Pilot Research Award, American Gastroenterological Association, 2023
- Pilot/Feasibility Award, UCSF Liver Center, 2023
- Clinical Research Pilot Study Award, American College of Gastroenterology, 2021
- AASLD Foundation Fellow Abstract Award, Digestive Disease Week, 2021
- Best of the Liver Meeting, Basic and Translational Research, AASLD, 2020
- Honors in Research, Mount Sinai Internal Medicine, 2018
- Presidential Poster of Distinction, AASLD, 2014
- Howard Hughes Medical Research Fellowship, Howard Hughes Medical Institute, 2013-2014
- Mount Sinai Research Scholars Program, Icahn School of Medicine at Mount Sinai, 2011
- Undergraduate Teaching and Research Award, Brown University, 2008
- Summer Medical and Research Training Program Fellowship, Baylor College of Medicine, 2007
Education & Training
Show all (6) Hide
- Fellowship Transplant Hepatology UCSF 2022
- Fellowship Gastroenterology Brigham and Women's Hospital 2021
- MPH Clinical Effectiveness Harvard TH Chan School of Public Health 2021
- Residency Internal Medicine The Mount Sinai Hospital 2018
- MD Icahn School of Medicine at Mount Sinai 2015
- BS Biology Brown University 2010
Interests
Show all (4) Hide
- immunotherapy
- primary sclerosing cholangitis
- hepatocellular carcinoma
- autoimmune liver disease
Grants and Projects
Show all (2) Hide
- Predictors and biomarkers of immunotherapy response and toxicity in hepatocellular carcinoma, The American College of Gastroenterology, 2023-2026
- Novel proteome-wide autoantibody discovery in primary sclerosing cholangitis, PSC Partners, 2023-2025
Publications (10)
Top publication keywords:
HIV Protease InhibitorsChorioallantoic MembraneHepatitisHyperbilirubinemiaMethylprednisoloneXenograft Model Antitumor AssaysNeoplasm TransplantationAlanine TransaminaseDose-Response Relationship, ImmunologicEsophageal and Gastric VaricesChemical and Drug Induced Liver InjuryMelanomaAtazanavir SulfateDose-Response Relationship, DrugGastrointestinal Hemorrhage
-
Early Liver Specialist Consultation is Associated With Faster Biochemical Resolution of Severe Immune Checkpoint Inhibitor-Induced Hepatitis.
Journal of the National Comprehensive Cancer Network : JNCCN 2023 Li M, Wong D, Sack JS, Vogel AS, Hodi FS, Fong L, Lai JC, Grover S, Zucker SD -
Diagnosis and Management of Drug-Induced Liver Injury After the Use of Polygonum multiflorum.
ACG case reports journal 2022 Zahir A, Li M, Gill RM, Brandman D -
Effect of corticosteroid dosing on outcomes in high-grade immune checkpoint inhibitor hepatitis.
Hepatology (Baltimore, Md.) 2021 Li M, Wong D, Vogel AS, Sack JS, Rahma OE, Hodi FS, Zucker SD, Grover S -
Utility of Liver Biopsy in Diagnosis and Management of High-grade Immune Checkpoint Inhibitor Hepatitis in Patients With Cancer.
JAMA oncology 2021 Li M, Sack JS, Bell P, Rahma OE, Srivastava A, Grover S, Zucker SD -
Letter to the Editor: Endoscopic Ultrasound-Guided Coil Therapy for Secondary Prevention After Gastric Variceal Bleeding: A Promising Alternative.
Hepatology (Baltimore, Md.) 2021 Bazarbashi AN, Li M, Ryou M
Show all (5 more) Hide
-
Bleeding Outcomes Following Transesophageal Echocardiography in Patients With Cirrhosis and Esophageal Varices.
Hepatology communications 2020 Sack JS, Li M, Zucker SD -
Predictors of Outcomes of COVID-19 in Patients With Chronic Liver Disease: US Multi-center Study.
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2020 Kim D, Adeniji N, Latt N, Kumar S, Bloom PP, Aby ES, Perumalswami P, Roytman M, Li M, Vogel AS, Catana AM, Wegermann K, Carr RM, Aloman C, Chen VL, Rabiee A, Sadowski B, Nguyen V, Dunn W, Chavin KD, … -
Association Between Atazanavir-Induced Hyperbilirubinemia and Cardiovascular Disease in Patients Infected with HIV.
Journal of the American Heart Association 2020 Li M, Chan WW, Zucker SD -
Outcomes after resumption of immune checkpoint inhibitor therapy after high-grade immune-mediated hepatitis.
Cancer 2020 Li M, Sack JS, Rahma OE, Hodi FS, Zucker SD, Grover S -
The In Ovo Chick Chorioallantoic Membrane (CAM) Assay as an Efficient Xenograft Model of Hepatocellular Carcinoma.
Journal of visualized experiments : JoVE 2015 Li M, Pathak RR, Lopez-Rivera E, Friedman SL, Aguirre-Ghiso JA, Sikora AG